- Home
- MYND vs ANVS Comparison
MYND vs ANVS Comparison
Compare MYND & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYND
- ANVS
- Stock Information
- Founded
- MYND 1998
- ANVS 2008
- Country
- MYND Cayman Islands
- ANVS United States
- Employees
- MYND N/A
- ANVS N/A
- Industry
- MYND Other Consumer Services
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- MYND Real Estate
- ANVS Health Care
- Exchange
- MYND Nasdaq
- ANVS Nasdaq
- Market Cap
- MYND 38.8M
- ANVS 31.2M
- IPO Year
- MYND 2017
- ANVS 2020
- Fundamental
- Price
- MYND $0.85
- ANVS $1.58
- Analyst Decision
- MYND
- ANVS Strong Buy
- Analyst Count
- MYND 0
- ANVS 5
- Target Price
- MYND N/A
- ANVS $37.00
- AVG Volume (30 Days)
- MYND 16.5K
- ANVS 259.9K
- Earning Date
- MYND 04-08-2025
- ANVS 05-12-2025
- Dividend Yield
- MYND N/A
- ANVS N/A
- EPS Growth
- MYND N/A
- ANVS N/A
- EPS
- MYND N/A
- ANVS N/A
- Revenue
- MYND $267,380,999.00
- ANVS N/A
- Revenue This Year
- MYND N/A
- ANVS N/A
- Revenue Next Year
- MYND N/A
- ANVS N/A
- P/E Ratio
- MYND N/A
- ANVS N/A
- Revenue Growth
- MYND N/A
- ANVS N/A
- 52 Week Low
- MYND $0.61
- ANVS $1.43
- 52 Week High
- MYND $4.69
- ANVS $20.00
- Technical
- Relative Strength Index (RSI)
- MYND 33.54
- ANVS 35.70
- Support Level
- MYND $0.84
- ANVS $1.43
- Resistance Level
- MYND $0.90
- ANVS $2.07
- Average True Range (ATR)
- MYND 0.08
- ANVS 0.15
- MACD
- MYND 0.01
- ANVS 0.04
- Stochastic Oscillator
- MYND 5.88
- ANVS 23.44
About MYND Mynd.ai Inc.
Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.